INSIGHTS ON DRUG DEVELOPMENT

• Solubility And Improved Patient Outcomes

  Poor solubility poses major development challenges. Innovative formulation technologies and careful excipient selection can improve bioavailability and product performance.

• History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era

  Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.

• Making Accelerated Predictive Stability Studies Even Faster With Software

  Drug stability depends on environmental conditions, but testing every scenario experimentally isn’t practical. Accelerated predictive stability uses mathematical modeling to forecast degradation, helping scientists make faster, data-driven decisions early in development.

• Get More From Less: AMP Chemistry Outperforms Hybrid Capture

  Sequencing performance can drop quickly with low-quality, low-input FFPE DNA. Gain insight into how one approach helps labs minimize repeats and maintain more consistent results.

• Development Of Scalable Purification For Biotherapeutic Peptides

  8/26/2025

  Discover key strategies for reversed-phase isolation of biotherapeutic peptides, as well as learn about method development, scale-up techniques, and RP/MS analysis to enhance purification workflows.

• The Simplest, Most Powerful Digital PCR Workflow Family

  3/26/2026

  Scalable digital PCR provides high-throughput automation for up to 384 samples. Support seven-color multiplexing and 3D data analysis to achieve superior sensitivity and streamlined laboratory workflows.

• Transformative Innovation: Advancing Drug Development Using In Silico Modeling

  3/4/2026

  Explore how predictive modeling and in silico strategies can turn complex data into actionable insights that accelerate drug development and reduce risk across the development lifecycle.

• Integrating High-Content Imaging With Traditional Plate-Based Screening

  5/6/2026

  Gain mechanistic insights beyond traditional viability assays, revealing nuanced cellular phenotypes and strengthening early drug discovery decisions without sacrificing throughput or efficiency.

• Best-In-Class Nanodevelopment Capabilities

  2/3/2025

  A highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.